Advancing RSV research: Expanding therapeutic options with recombinant antibodies and antigens

Human respiratory syncytial virus (RSV) remains a significant public health concern, particularly for vulnerable populations such as infants, young children, and immunocompromised individuals. In this webinar, Sino Biological will highlight the crucial role of RSV antigens and antibodies in research and the development of diagnostics, therapeutics, and vaccines against RSV, as well as a comprehensive overview of RSV, highlighting its epidemiology, clinical manifestations, and associated complications.

About the Speaker

Dr. Mohammad Safiarian is the Associate Product Manager at Sino Biological, where he is responsible for product development and marketing of protein products. He earned his Ph.D. in Biochemistry from Georgia State University and completed post-doctoral training at the Georgia Institute of Technology and Baylor College of Medicine. Dr. Safiarian's expertise lies in protein science, DNA biochemistry, and enzymology, and he has authored several peer-reviewed papers with over 100 citations.